Hydrogen sulfide: a new regulator of osteoclastogenesis?
Hydrogen sulfide: a new regulator of osteoclastogenesis?
复制标题
DOI:
10.1161/atvbaha.114.303072
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
M. Kurabayashi
中科院分区:
文献类型:
--
作者:
M. Kurabayashi
These results represent a potential breakthrough in the understanding of the modulation of RANKL-induced osteoclastogenesis. However, it is not clear how H2S exerts its osteoclestogenic effects on RANKL-stimulated RAW264. 7 cells. Previous studies have demonstrated that H2S is an important endogenous vasoactive factor that protects arteries from atherosclerotic damage, including inflammation, endothelial dysfunction, vascular SMC proliferation, and migration. 17, 18 The antiatherogenic effects of H2S have been ascribed to its antioxidant effect because treatment of CSE-deficient, atherogenic diet–fed mice with an H2S donor resulted in decreased oxidative stress. 19 Taking these data into consideration, Itou et al alluded that the vasoprotective effect of H2S contributes to the acceleration of osteoclast differentiation in response to the H2S donor GYY4137. The finding of Itou et al of the effects of H2S on osteoclast differentiation seems to be supported by several previous studies demonstrating that increased intracellular levels of the antioxidant glutathione enhance osteoclast development and bone pit formation, and glutathione depletion by L-buthionine-(S, R)-sulfoximine, a specific inhibitor of glutathione synthesis, inhibits osteoclastogenesis in RANKL-stimulated RAW264. 7 cells. 20 Nevertheless, there have been several studies challenging this hypothesis; reactive oxygen species produced in macrophages are essential for osteoclast differentiation21; the administration of antioxidants completely prevented bone loss in ovariectomized mice22; and several signaling components essential for RANKL-induced osteoclast differentiation are activated by reactive oxygen species, including tumor necrosis factor receptor–associated factor 6, nuclear factor κB, c-Fos, nuclear factor of activated cells, p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, extracellular signal-regulated kinase, and NADPH oxidase. 23 These controversies would be reconciled by the notion that redox shift caused by the change in oxidative stress or antioxidant defense exerts its bimodal effects on cellular function depending on the cellular redox status. Thus, it is intriguing to speculate that the robustness of RANKL-induced osteoclast differentiation is dependent on the redox state of precursor cells that is regulated by H2S generated by CSE.What are the potential clinical implications of this study? Clearly, additional work is required to determine whether H2S production or CSE activity is implicated in osteoclast differentiation in vivo. Moreover, it is yet to be determined whether osteoclast response to H2S is differentially regulated between bone and vasculature. Although the relationship between osteoporosis and vascular calcification has long been known as calcification paradox, its precise molecular mechanism remains unclear. It is reassuring that calcium paradox is not merely because of calcium shift from bone to artery wall but is likely because of the differential response of both osteoblasts and osteoclasts to oxidative stress between bone and artery. 24 In the past, many studies have highlighted the important role for RANK/RANKL/OPG axis for the apparently opposite regulation of calcification between 2 tissues. 8–15 The report by Itou et al brings a new perspective to the regulatory mechanisms of osteoclast differentiation and may open new avenues to the identification of a promising target for the prevention and treatment of vascular calcification.